5I76
Crystal structure of FM318, a recombinant Fab adopted from cetuximab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 7A (6B, 6C1) |
Synchrotron site | PAL/PLS |
Beamline | 7A (6B, 6C1) |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-09-30 |
Detector | ADSC QUANTUM 270 |
Wavelength(s) | 1.0000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 72.482, 68.037, 97.689 |
Unit cell angles | 90.00, 101.85, 90.00 |
Refinement procedure
Resolution | 27.717 - 1.922 |
R-factor | 0.1677 |
Rwork | 0.166 |
R-free | 0.20100 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1yy8 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.135 |
Refinement software | PHENIX ((1.10.1_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 27.720 | 1.960 |
High resolution limit [Å] | 1.920 | 1.930 |
Number of reflections | 69631 | |
<I/σ(I)> | 45.25 | 11.26 |
Completeness [%] | 98.4 | 97.4 |
Redundancy | 7.5 | 7.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 290 | 20% (w/v) PEG 3000 100 mM Imidazole/ Hydrochloric acid pH 8.0 200 mM Zinc acetate |